Showing results (201-210 of 210) with videos related to
Sort By:
Pageof 21
You have reached the last page of results.This site can display upto 210 results.
International Journal of Cancer|January 7, 2020
Ovarian cancer-associated mesothelial cells induce acquired platinum-resistance in peritoneal metastasis via the FN1/Akt signaling pathwayMasato Yoshihara, Hiroaki Kajiyama, Akira Yokoi, et al.Plant Physiology|September 20, 2022
Lignocellulose molecular assembly and deconstruction properties of lignin-altered rice mutantsAndri Fadillah Martin, Yuki Tobimatsu, Pui Ying Lam, et al.Oncotarget|December 31, 2016
Perioperative plasma glypican-3 level may enable prediction of the risk of recurrence after surgery in patients with stage I hepatocellular carcinomaKazuya Ofuji, Keigo Saito, Shiro Suzuki, et al.BMC Cancer|December 1, 2020
Propensity score-matched analysis of systemic chemotherapy versus salvage hysterectomy for persistent cervical cancer after definitive radiotherapy/concurrent chemoradiotherapyMunetaka Takekuma, Fumiaki Takahashi, Seiji Mabuchi, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 5, 2026
Tisotumab vedotin in Japanese patients with recurrent or metastatic cervical cancer: results from the innovaTV 301/ENGOT-cx12/GOG-3057 trialKan Yonemori, Shin Nishio, Shiro Suzuki, et al.Cancer Immunology, Immunotherapy : CII|June 2, 2026
Integrated immunophenotypic and ProMisE molecular profiling as predictors of immune checkpoint inhibitor response in recurrent endometrial cancerKomei Katayama, Nobuhisa Yoshikawa, Wenting Liu, et al.Journal of Gynecologic Oncology|February 1, 2024
Analysis of East Asia subgroup in Study 309/KEYNOTE-775: lenvatinib plus pembrolizumab versus treatment of physician's choice chemotherapy in patients with previously treated advanced or recurrent endometrial cancerKan Yonemori, Keiichi Fujiwara, Kosei Hasegawa, et al.Gynecologic Oncology|July 21, 2023
Clinical characteristics and prognostic factors of endometrial stromal sarcoma and undifferentiated uterine sarcoma confirmed by central pathologic review: A multi-institutional retrospective study from the Japanese Clinical Oncology GroupAkira Kikuchi, Hiroshi Yoshida, Hitoshi Tsuda, et al.Journal of Cancer|February 19, 2024
Proposal for Classifying the Emetogenicity of Oral Anticancer Agents with a Focus on PARP Inhibitors: A Prospective, Observational, Multicenter Study (JASCC-CINV 2002)Senri Yamamoto, Masami Tsuchiya, Hirotoshi Iihara, et al.Journal for Immunotherapy of Cancer|February 19, 2026
Lenvatinib plus pembrolizumab in previously treated advanced endometrial cancer: 5-year outcomes from the randomized, phase 3 Study 309/KEYNOTE-775Vicky Makker, Nicoletta Colombo, Antonio Casado, et al.Pageof 21